Study finds nearly half of cancer survivors died from conditions other than cancer
Although cancer recurrence may be the overriding fear for many survivors, a study from VCU Massey Cancer Center found only 51 percent of cancer survivors died from cancer, meaning nearly half of survivors died from other conditions. These results indicate survivors could potentially benefit from a more comprehensive, less cancer-focused approach to their health, according to lead researcher Yi Ning, M.D., Sc.D., assistant professor in the department of epidemiology and community health at Virginia Commonwealth University (VCU) and associate research member at VCU Massey Cancer Center.
VCU Massey Cancer Center physicians top Richmond Magazine’s 2012 Top Doctors list
Physicians at Virginia Commonwealth University (VCU) Massey Cancer Centerwere recognized as “Top Docs” in Richmond Magazine‘s April 2012 issue. Topping the list were 33 doctors from varied specialties who provide oncology-related care to Massey’s patients. These doctors were selected through a survey of Richmond-area physicians which asked who they would recommend in a range of specialties.
Researchers identify a new way to reduce the spread of brain cancer
Scientists at Virginia Commonwealth University’s (VCU) Massey Cancer Center and Harold F. Young Neurosurgical Center with researchers at Old Dominion University have discovered a mechanism in glioblastoma (GBM) cells, the most common and aggressive form of brain cancer, that promotes the disease’s characteristic invasiveness. This finding could potentially lead to new therapies for this difficult-to-treat disease.
New technology could detect liver cancer from a simple blood sample
New technology from ApoCell, Inc. that can detect liver cancer cells circulating in a patient’s bloodstream may remove the need for potentially dangerous liver biopsies, be used as a screening tool and, ultimately, speed up drug development, according to a pilot study presented this week by Virginia Commonwealth University (VCU) Massey Cancer Center researcher Andrew Poklepovic, M.D., at the AACR Annual Meeting 2012 in Chicago, IL.
New compound discovered that rapidly kills liver cancer
Scientists have identified a new compound that rapidly kills hepatocellular carcinoma (HCC) cells, the most common form of liver cancer and fifth most common cancer worldwide, while sparing healthy tissue. The compound, Factor Qunolinone Inhibitor 1 (FQI1), works by inhibiting an oncogene originally discovered by a team of researchers led by Devanand Sarkar, M.B.B.S., Ph.D., Harrison Scholar at Virginia Commonwealth University (VCU) Massey Cancer Center, Blick Scholar and assistant professor in the Department of Human and Molecular Genetics and member of the VCU Institute of Molecular Medicine at VCU School of Medicine.